昭衍新药 funding history / development milestones

IPO上市,主板

2017.08.25,上交所

Note: collected from public online reports, for reference only.

People who follow 昭衍新药 also follow

昭衍新药 Competitors (Similar Companies)

医药 药效学研究 生物制品 生物医药
医药 新药研发 CRO 医药CRO
“Promoting human health”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Adhering to the corporate culture of science and excellence, committed”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Optical module solutions and service provider”
海运 散货船 船舶管理 货运
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Core Mission: Safeguarding Human Health with Life Sciences”
中间体 生产 原料药 中间体生产
“To develop high-quality biologics that are accessible and affordable f”
“Helping people live healthier and happier lives”
“风塔、叶片装备制造龙头企业”
“Use creativity and technology to drive business and social progress”